 |
Top 10 Neurology startups
Updated: May 01, 2024 | Editor: Jason Kwon |
Neurology startups are pushing the boundaries of innovation in the field by leveraging emerging technologies like virtual reality (VR), machine learning (ML), and brain-computer interfaces (BCIs) to revolutionize diagnosis, treatment, and patient care. These startups are developing cutting-edge solutions that enable precise neuroimaging, personalized therapy, and enhanced rehabilitation techniques, ultimately improving the lives of individuals with neurological conditions.
1
Country: USA | Funding: $612M
Neumora Therapeutics is pioneering a new era of precision medicines for Brain Diseases
Neumora Therapeutics is pioneering a new era of precision medicines for Brain Diseases
2
Country: USA | Funding: $544.8M
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
3
Country: France | Funding: $356.6M
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
4
Country: USA | Funding: $307.3M
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
5
Country: USA | Funding: $260M
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
6
Country: USA | Funding: $220.5M
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective
7
Country: USA | Funding: $194.5M
Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.
Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.
8
Country: USA | Funding: $181.2M
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
9
Country: UK | Funding: $159.6M
PepGen is empowering nucleic acid therapeutics to go the distance and building neuromuscular and neurologic pipeline.
PepGen is empowering nucleic acid therapeutics to go the distance and building neuromuscular and neurologic pipeline.
10
Country: USA | Funding: $157.2M
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
11
Country: USA | Funding: $115.1M
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
12
Country: USA | Funding: $109M
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
13
Country: USA | Funding: $101.5M
Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. Our product candidates utilize our proprietary Precisa development platform that are based on specific physical and chemical properties that enable targeted delivery to the exact site of the injury, and provide a controlled and sustained drug release to the affected area.
Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. Our product candidates utilize our proprietary Precisa development platform that are based on specific physical and chemical properties that enable targeted delivery to the exact site of the injury, and provide a controlled and sustained drug release to the affected area.
14
Country: USA | Funding: $73.7M
Neural Analytics is addressing the global traumatic brain injury epidemic through data science. The company develops robotically assisted ultrasound system for brain health assessment. The company’s technology integrates ultrasound, robotics and machine learning to empower neurologists with critical information about brain health
Neural Analytics is addressing the global traumatic brain injury epidemic through data science. The company develops robotically assisted ultrasound system for brain health assessment. The company’s technology integrates ultrasound, robotics and machine learning to empower neurologists with critical information about brain health
15
Country: USA | Funding: $42.5M
Cervel Neurotech is a privately held medical device company, pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. Cervel Neurotech is pioneering a new approach to an established technology – repetitive transcranial magnetic stimulation (rTMS) – designed to produce better outcomes and a more comfortable treatment for patients.
Cervel Neurotech is a privately held medical device company, pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. Cervel Neurotech is pioneering a new approach to an established technology – repetitive transcranial magnetic stimulation (rTMS) – designed to produce better outcomes and a more comfortable treatment for patients.
16
Country: USA | Funding: $41.3M
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future.
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future.
17
Country: Israel | Funding: $30.5M
Developer of neurology software designed to help patients affected by neurological disorders.
Developer of neurology software designed to help patients affected by neurological disorders.
18
Country: Australia | Funding: AUD$34M
Seer is a medical technology company that specializes in addressing neurological conditions. It created at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
Seer is a medical technology company that specializes in addressing neurological conditions. It created at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
19
Country: Australia | Funding: $20.8M
Global Kinetics Corporation develops movement recording tool for neurologists in the management of Parkinson’s disease.
Global Kinetics Corporation develops movement recording tool for neurologists in the management of Parkinson’s disease.
20
Country: USA | Funding: $14.4M
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
21
Country: South Korea | Funding: $13.4M
Through use of technology in which measures and modulates brain signals, we develop research protocols that improve cognitive functions. We provide meaningful information retrieved from the wearable devices through analysis of brain signal big data. With this big data, we predict and diagnose the stages of the neurological diseases such as Alzheimer’s disease and mild cognitive impairment.
Through use of technology in which measures and modulates brain signals, we develop research protocols that improve cognitive functions. We provide meaningful information retrieved from the wearable devices through analysis of brain signal big data. With this big data, we predict and diagnose the stages of the neurological diseases such as Alzheimer’s disease and mild cognitive impairment.
22
Country: Singapore | Funding: $12.3M
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of neurodegenerative disease.
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of neurodegenerative disease.
23
Country: Canada | Funding: $6.8M
Patented, AI-Powered, mobile software, eye tracking technology that captures digital Eye Movement Biomarkers to monitor disease status & progression in neurodegenerative and mental disorders.
Patented, AI-Powered, mobile software, eye tracking technology that captures digital Eye Movement Biomarkers to monitor disease status & progression in neurodegenerative and mental disorders.
24
Country: Switzerland | Funding: 3
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
25
Country: USA
Cortera Neurotechnologies designs medical devices aimed at revolutionizing the treatment of intractable neurological conditions.
Cortera Neurotechnologies designs medical devices aimed at revolutionizing the treatment of intractable neurological conditions.
26
Country: Germany
Priavoid envisions curing neurological disorders by developing innovative treatment strategies based on a new class of orally available compounds. Focusing on indications with significant unmet medical need Priavoid applies the therapeutic concept to Alzheimer’s disease (AD), neuropathic pain and other neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS), tauopathies, Parkinson’s disease (PD), and Huntington’s disease (HD).
Priavoid envisions curing neurological disorders by developing innovative treatment strategies based on a new class of orally available compounds. Focusing on indications with significant unmet medical need Priavoid applies the therapeutic concept to Alzheimer’s disease (AD), neuropathic pain and other neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS), tauopathies, Parkinson’s disease (PD), and Huntington’s disease (HD).
27
Country: Australia
GenieUs Genomics analyses the sequencing data of each patient and turn human biological information into code to treat neurodegenerative diseases.
GenieUs Genomics analyses the sequencing data of each patient and turn human biological information into code to treat neurodegenerative diseases.
28
Country: Serbia
NeuroBlast is a sensory device that helps children and adults with neurodegenerative diseases exercise continuously at home, during post-rehabilitation. This simple interactive device incorporates video gamification to encourage users to complete at-home physical therapy in a fun and soothing manner.
NeuroBlast is a sensory device that helps children and adults with neurodegenerative diseases exercise continuously at home, during post-rehabilitation. This simple interactive device incorporates video gamification to encourage users to complete at-home physical therapy in a fun and soothing manner.
29
Country: USA
VistaraBio is applying their proteostasis technologies for target identification in Parkinson's and other neurodegenerative diseases.
VistaraBio is applying their proteostasis technologies for target identification in Parkinson's and other neurodegenerative diseases.
